Completed × Breast Neoplasms × liposomal doxorubicin × Clear all Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Phase 2 Completed
29 enrolled 15 charts
Doxil/Caelyx BE Study
Phase 1 Completed
36 enrolled
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
Phase 2 Completed
9 enrolled 10 charts
ALICE
Phase 2 Completed
68 enrolled
ICON
Phase 2 Completed
82 enrolled
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
Phase 2 Completed
17 enrolled 5 charts
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Phase 2 Completed
49 enrolled 16 charts
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
Phase 3 Completed
1,925 enrolled 19 charts
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Phase 4 Completed
288 enrolled
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Phase 2 Completed
31 enrolled 11 charts
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase 1 Completed
7 enrolled
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Phase 1/2 Completed
2 enrolled 1 chart
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
Completed
760 enrolled
Stop&Go
Phase 3 Completed
420 enrolled
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
Phase 2 Completed
27 enrolled 5 charts
Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Phase 1 Completed
45 enrolled
Opti-HER
Phase 2 Completed
83 enrolled
CAPRICE
Phase 2 Completed
50 enrolled
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Phase 1/2 Completed
30 enrolled 13 charts
Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Phase NA Completed
100 enrolled
The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)
Phase 3 Completed
210 enrolled 11 charts
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)
Phase 2 Completed
181 enrolled 9 charts
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
Phase 2 Completed
136 enrolled 11 charts
Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin
Phase 2 Completed
32 enrolled 7 charts
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
Phase 1/2 Completed
45 enrolled 8 charts
A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Phase 1 Completed
54 enrolled
Caelyx Adjuvant in Elderly Breast Cancer
Phase 2 Completed
16 enrolled
A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)
Completed
167 enrolled 10 charts
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
Phase 2 Completed
84 enrolled 9 charts
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer
Phase 3 Completed
751 enrolled 10 charts
Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer
Phase 1 Completed
23 enrolled
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
Phase 1 Completed
20 enrolled 9 charts
Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
Phase 2 Completed
102 enrolled 7 charts
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Phase 1/2 Completed
107 enrolled
Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer
Phase 2 Completed
45 enrolled
Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
Phase 2 Completed
67 enrolled